| Pharmaceutical active ingredients: |
| GramicidinNeomycin SulfatePolymyxin B Sulfate |
| Available forms, composition and doses of Neosporin: |
| Cream; Topical; Neomycin Sulfate 3.5 mg; Polymyxin B Sulfate 10,000 units / gOintment; Ophthalmic; Neomycin Sulfate 400 units; Gramicidin 3.5 mg; Polymyxin B Sulfate 10,000 units / gPowder; Topical; Gramicidin; Neomycin Sulfate; Polymyxin B SulfateSolution; Irrigation; Neomycin Sulfate 40 mg; Polymyxin B Sulfate 200,000 units / mlSolution; Ophthalmic; Gramicidin 0.025 mg; Neomycin Sulfate 1.75 mg; Polymyxin B Sulfate 10,000 units / mlSolution; Ophthalmic; Gramicidin 0.025 mg; Neomycin Sulfate 3400 units; Polymyxin B Sulfate 5000 units / ml |
| Neosporin medical category: |
| Human:AntibacterialsAntibioticsEye anti-infectives and antiseptics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| S01AA30 - Combinations of different antibioticsS03AA30 - Antiinfectives, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| GlaxoSmithKlineFirma Chun CheongKing PharmaceuticalsMonarch PharmaceuticalsPfizerPlivaZuellig Pharma |
| Related documents and information about Neosporin: |
| Neosporin prescribing information (PDF) |